Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors

Figure 2

Kaplan-Meier estimates for (a) overall survival (5-year 88.1%), (b) distant metastases-free survival (5-year 86.0%), and (c) disease-free survival (5-year 83.0%).

(a)

(b)

(c)